Company intelligence / Profile preview

Guangxi Wantong Pharmaceutical

Guangxi Zhuang Autonomous Region, Chinamarketscreener.com ↗

Ownership: Private
Development stage: Commercial

Overview

Guangxi Wantong Pharmaceutical specializes in R&D, production, and sales of traditional Chinese medicine patent drugs. In 2017 it had a revenue of approximately 120 million yuan (~~$18M USD) with net profit of about 66 million yuan (~~$10M USD). The company demonstrated steady growth through at least September 2018. No specific clinical trial results are reported.

Modalities: Small moleculeTraditional Chinese Medicine
Industry: Biotech

Drug pipeline

1 asset

compound jinqiancao

Unknown

Partnerships

Acquired via investment partnership led by parent company and financial investors

Beyond the preview

Go deeper on Guangxi Wantong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangxi Wantong Pharmaceutical.

Explore the full profile